HSCL2024-04-012024-06-30 HSCL2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member HSCL2024-06-30 HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue01Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue02Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults01Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults02Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets01Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets02Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member HSCL2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member HSCL2024-04-012024-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500184 HSCL NA Himadri Speciality Chemical Limited Equity 2024-04-01 2025-03-31 2024-07-16 2024-07-09 INR Crores First quarter 11:45:00 14:10:00 2024-07-16 2024-07-16 Not applicable Multi segment 2024-04-01 2024-06-30 Unaudited Consolidated 12004100000.00 126400000.00 12130500000.00 8287200000.00 0.00 210500000.00 314600000.00 129500000.00 129300000.00 1272600000.00 10343700000.00 1786800000.00 0.00 1786800000.00 314200000.00 244800000.00 559000000.00 0.00 1227800000.00 0.00 0.00 0.00 0.00 1227800000.00 10700000.00 1238500000.00 1226200000.00 1600000.00 1236800000.00 1700000.00 493500000.00 1 2.49 2.48 0.00 0.00 2.49 2.48 1. The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 16 July 2024. A Limited Review of these consolidated financial results for the quarter ended 30 June 2024 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulations, 2015. 2. Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs (4.31) crores for the quarter ended 30 June 2024, Re (0.65) crore for the quarter ended 31 March 2024, Rs (4.11) crores for the quarter ended 30 June 2023 and Rs (9.68) crores for the year ended 31 March 2024. Finance cost includes exchange difference regarded as an adjustment to borrowing costs in accordance with Ind AS 23, of Re Nil for the quarter ended 30 June 2024, Re 0.49 crore for the quarter ended 31 March 2024, Re 0.50 crore for the quarter ended 30 June 2023 and Rs 3.12 crores for the year ended 31 March 2024. 3. Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within two operating segments, namely: (a) Carbon materials and chemicals, and (b) Power 4. The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited, Combe Projects Private Limited (w.e.f 20 July 2023), Himadri Clean Energy Limited (w.e.f 30 November 2023) and Himadri Future Material Technology Limited (w.e.f 01 February 2024) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). The Holding Company has acquired 40% paid-up share capital of M/s. Invati Creations Private Limited (ICPL) and this voting right does not qualify ICPL as a subsidiary under Section 2(87) of the Companies Act, 2013. However based on contractual rights (including potential voting right combined with 40% voting right), the Holding Company has the power to make decisions concerning relevant activities and thus has control over ICPL as per IND AS 110: Consolidated Financial Statements. Consequently, the management of the Holding Company has decided to consolidate the financial results of ICPL as a subsidiary with effect from May 17, 2024. The consolidated financial results are prepared applying uniform accounting policies on all material items. 5. The Holding Company has issued and allotted 10,817,000 warrants, each convertible into one equity share of Re 1 each, on Preferential allotment basis at an issue price of Rs 316 per warrant, to the Promoters of the Holding Company and certain identified non-promoter persons, upon receipt of 25% of the issue price (i.e. Rs 79 per warrant) as warrant subscription money. Balance 75% of the issue price (i.e. Rs 237 per warrant) shall be payable within 18 months from the date of allotment i.e.14 May 2024, at the time of exercising the option to apply for fully paid-up equity share of Re 1 each of the Holding Company, against each warrant held by the warrant holder. Other Expenses 1272600000.00 Carbon materials and chemicals 11943400000.00 Power 258500000.00 12201900000.00 197800000.00 12004100000.00 Carbon materials and chemicals 1515500000.00 Power 231300000.00 1746800000.00 129500000.00 -169500000.00 Other unallocable expenses net of unallocable income includes other income, foreign exchange loss/ (gain) (net), and exceptional items fully unallocable. Notes (Contd..) 6. The consolidated figures for the three months ended 31 March 2024 as reported in these consolidated financial results are the balancing figures between audited figures in respect of the full financial year and the published year to date consolidated figures up to the end of the nine months of the relevant financial year. Also the consolidated figures up to the third quarter had only been reviewed and not subjected to audit. 7. The Holding Company on 17 May 2024, has acquired 40% paid-up equity share capital of Invati Creations Private Limited (“Target Company”), for a total purchase consideration of Rs 45.16 crores. The purchase consideration has been discharged in the following manner – i. Rs 19.99 crores has been paid in cash against fresh issue of 2,152 equity shares of Rs 10/- each constituting 17.71% stake, of the Target Company; and ii. Rs 25.17 crores payable for acquiring 2,709 equity shares of Rs. 10 each, constituting 22.29% stake, of the Target Company from the existing shareholders of the Target Company for consideration other than cash has been settled by way of issue and allotment of 7,96,446 equity shares of the Holding Company having face value of Re 1/- each, at a price of Rs 316 per equity share (including a premium of Rs 315 (Rupees Three Hundred Fifteen only) per equity share to the existing shareholders of the Target Company. 8. The Holding Company on 17 May 2024, has allotted 7,96,446 equity shares of Re 1 each, at an issue price of Rs 316 per equity share, on a preferential basis for consideration other than cash towards payment of Rs 25.17 crores ( Purchase Consideration ), payable by the Holding Company to the Allottees who are not Promoter(s) and who do not belong to the Promoter Group of the Company, as consideration for acquisition of 2,709 equity shares of Rs 10 each of Invati Creations Private Limited (“Target Company”), representing 22.29% paid-up equity capital of the Target Company held by the Allottees. As a result of such allotment, the paid up equity share capital of the Holding Company has increased from 492,718,688 equity shares to 493,515,134 equity shares of face value of Re 1 each. 9. Earnings per share is not annualised for the quarter ended 30 June 2024, 31 March 2024 and 30 June 2023. 1786800000.00 Carbon materials and chemicals 31116100000.00 Power 1052700000.00 32168800000.00 11507000000.00 43675800000.00 Carbon materials and chemicals 3823800000.00 Power 4100000.00 3827900000.00 7092200000.00 10920100000.00 Remeasurements of the net defined benefit plan -500000.00 Net gain/ (loss) on investment in equity instruments accounted at fair value 14700000.00 14200000.00 1600000.00 Exchange differences in translating financial statements of foreign operations -1900000.00 -1900000.00 0.00